🕵️ Semnur Pharmaceuticals, Inc. ($SMNR)
SEC insider & ownership activity, last 12 months · CIK 1913577 · every row links its SEC filing
Insider sell value was withheld pending verification over the last 12 months. Scilex Holding Company trimmed 82.1% → 78.8%; Scilex, Inc. trimmed 79.1% → 75.9%. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 1 seller, value withheld pending verification (2 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Scilex Holding Co | 0 | – | 2 | value withheld pending verification | Sep 23, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Scilex Holding Company | 78.8% | 13D | Jun 15, 2026 | filing ↗ | |
| Scilex, Inc. | 75.9% | 13D | Jun 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jul 3, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jul 3, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 3, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 25, 2026 | filing ↗ |
| Agreement terminated (1.02) | Apr 20, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 13, 2026 | filing ↗ |
| Other events (8.01) | Dec 3, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 3, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 22, 2025 | filing ↗ |
| Acquisition or disposition (2.01) | Sep 22, 2025 | filing ↗ |
| New financial obligation (2.03) | Sep 22, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Sep 22, 2025 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Sep 22, 2025 | filing ↗ |
| Auditor change (4.01) | Sep 22, 2025 | filing ↗ |
| Change of control (5.01) | Sep 22, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 22, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Sep 22, 2025 | filing ↗ |
| Amendments to the Registrant's Code of Ethics (5.05) | Sep 22, 2025 | filing ↗ |
| Change in Shell Company Status (5.06) | Sep 22, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 22, 2025 | filing ↗ |
| Other events (8.01) | Sep 22, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 22, 2025 | filing ↗ |